Clinical Trial Update: Study to IDEntify Patients With Advanced/Metastatic Non Small Cell Lung Cancer (NSCLC) and ALK and ROS1 Translocation and to Establish Their Therapeutic Management (IDEALK&ROS)

View source ↗

Summary

This completed clinical trial (IDEALK&ROS) identifies patients with advanced/metastatic non-small cell lung cancer who harbor ALK or ROS1 translocations and aim…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Pfizer | Conditions: Non-Small Cell Lung Cancer | Status: COMPLETED | Results posted: 2024-08-09